A potential genetic protection against some blood cancers

Plus: A biotech incubator in China tries to unlock innovation — alongside drugmakers worldwide

January 6, 2026 Check out STAT+

Sponsored By

Jeff Pinette for STAT STAT+ | The top medical advances of 2025 New drugs reshaped care for HIV, obesity, lung cancer, and more in 2025. Prepare to hear more about drugs such as Yeztugo, Nuzolvence, Tagrisso and Enhertu. By Matthew Herper Genetic variant appears to protect some people against certain blood cancers The paper reveals a potential avenue to develop new therapeutics for a pre-cancerous condition called CHIP, which scientists have long sought By Angus Chen STAT+ | Insilico inks cancer drug deal with Servier after IPO Today's biotech news covers the first AI-powered biotech to list on the Hong Kong exchange's main board, the launch of a Wegovy pill, and more By Meghana Keshavan ATLATL STAT+ | A biotech incubator in China tries to unlock innovation — alongside drugmakers worldwide The incubator, founded by PC Zhu, believes it can allow researchers to test drug development ideas faster than in other countries, and at lower cost. By Brian Yang

More around STAT

---

In case you missed it Why flu seems to be everywhere — even if "super flu" is not a thing, STAT The U.S. endorses home pap smear alternative to prevent cervical cancer, WSJ Amgen buys cancer drug developer Dark Blue in $840M deal, Bloomberg

---

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2026, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser